News

Greg Crescenzi Joins Kytopen as Chief Commercial Officer to Drive Discovery, Development and...
BioCentriq™, the New Jersey Innovation Institute’s cell and gene therapy development and...
Kytopen co-founder Professor Cullen Buie studied mechanical engineering, first at Ohio State, then...
MIT spin-out company Kytopen has engaged Cambridge Consultants to co-develop the first Flowfect™...
Kytopen, an MIT spin-out company, and Cambridge Consultants, part of Capgemini, announce the...
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Kytopen, a technology startup accelerating the discovery and...
Merck, a leading science and technology company, today announced the winners of its Advance Biotech...
IF THE GENETIC REVOLUTION HAS YET TO DELIVER FULLY ON ITS PROMISE, Cullen Buie, associate professor...
The Engine, founded last year by MIT, today announced investments in its first group of seven...